Td Asset Management Inc Dice Therapeutics, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$19.77 - $42.23 $69,452 - $148,353
3,513 Added 6.14%
60,739 $1.9 Million
Q1 2022

May 10, 2022
BUY
$14.54 - $25.02 $142,492 - $245,196
9,800 Added 20.66%
57,226 $1.1 Million
Q4 2021

Feb 10, 2022
BUY
$22.41 - $37.54 $147,906 - $247,764
6,600 Added 16.17%
47,426 $1.2 Million
Q3 2021

Nov 09, 2021
BUY
$31.92 - $37.0 $1.3 Million - $1.51 Million
40,826 New
40,826 $1.34 Million

Others Institutions Holding DICE

# of Institutions
3
Shares Held
17.7K
Call Options Held
13K
Put Options Held
0
View Full List

About DICE Therapeutics, Inc.

DICE Quotes by TradingView
  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email